GEU20121749Y - Citrous diabetic syrup - Google Patents

Citrous diabetic syrup

Info

Publication number
GEU20121749Y
GEU20121749Y GEAU201012019U GEAU2010012019U GEU20121749Y GE U20121749 Y GEU20121749 Y GE U20121749Y GE AU201012019 U GEAU201012019 U GE AU201012019U GE AU2010012019 U GEAU2010012019 U GE AU2010012019U GE U20121749 Y GEU20121749 Y GE U20121749Y
Authority
GE
Georgia
Prior art keywords
syrup
citrous
diabetic
steviosides
vanillin
Prior art date
Application number
GEAU201012019U
Inventor
Givi Chitorelidze
Original Assignee
Givi Chitorelidze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givi Chitorelidze filed Critical Givi Chitorelidze
Priority to GEAU201012019U priority Critical patent/GEU20121749Y/en
Publication of GEU20121749Y publication Critical patent/GEU20121749Y/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Syrup of kg/100 dm3 contains: steviosides 0.3-0.35; citric acid 1.15-1.3; extracts of lemon 2.5-2.8, orange 2-2.2 and almond 0.002-0.003; vanillin 0.004-0.005; and the rest is water.
GEAU201012019U 2010-12-01 2010-12-01 Citrous diabetic syrup GEU20121749Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAU201012019U GEU20121749Y (en) 2010-12-01 2010-12-01 Citrous diabetic syrup

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAU201012019U GEU20121749Y (en) 2010-12-01 2010-12-01 Citrous diabetic syrup

Publications (1)

Publication Number Publication Date
GEU20121749Y true GEU20121749Y (en) 2012-12-10

Family

ID=79283586

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAU201012019U GEU20121749Y (en) 2010-12-01 2010-12-01 Citrous diabetic syrup

Country Status (1)

Country Link
GE (1) GEU20121749Y (en)

Similar Documents

Publication Publication Date Title
TW201711676A (en) Ferric citrate dosage forms
MX373230B (en) PHARMACEUTICAL COMPOSITION AND ITS ADMINISTRATION.
CL2009000905A1 (en) Edible composition comprising bifidobacterium longum atcc baa-999; and its use to treat or prevent anxiety and / or anxiety-related disorders.
MX2013001540A (en) Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof.
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
EP2513023A4 (en) COMPOSITIONS AND USES OF CIS-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
NZ596584A (en) Probiotic juice drink comprising at least one species of lactobacillus and fruit juices
WO2007054623A3 (en) Mammalian hedgehog signaling inhiabitors
EP2316412A3 (en) High-clarity aqueous concentrates of 4-hexylresorcinol
PH12013500104A1 (en) Cleansing composition with decyl and coco glucosides
MX2010002812A (en) Food compositions comprising lemon balm extracts.
TW200942530A (en) Pyridine compounds
GEP20146114B (en) New crystalline form vi of agomelatine, preparation method and application thereof
WO2010118291A3 (en) Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
MX2011012071A (en) Prevention and treatment of allergic diarrhoea.
MX2013002261A (en) Substituted n-phenethyltriazoloneacetamides and use thereof.
DK1880727T3 (en) Topical vaginal pharmaceutical compositions
MX2013002485A (en) Substituted phenylacetate and phenylpropane amides and use thereof.
WO2012084415A3 (en) Active ingredient combinations of glyceryl glucosides and one or more pearlescent agents and/or opacifiers
WO2011092655A3 (en) Mentha suaveolens essential oil and therapeutic activities thereof
WO2010129505A3 (en) Napthylene inhibitors of cyclooxygenase
김철수 How to improve the infrastructure and workforce of the long-term care insurance industry